Jazz Ducks BCBS Claims But Not Xyrem Class Cert.
A California federal judge granted class certification Friday to insurers and consumers pursuing multidistrict litigation accusing Jazz Pharmaceuticals of staving off generic competition to its blockbuster narcolepsy drug Xyrem through a...To view the full article, register now.
Already a subscriber? Click here to view full article